封面
市場調查報告書
商品編碼
1981779

透過生物技術製程實現化妝品的生物特性活性

Bio-Identical Actives in Cosmetics via Biotechnological Processes

出版日期: | 出版商: Frost & Sullivan | 英文 61 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球對永續和高效成分的需求正在推動以科學為先的新一代化妝品創新。

合成生物學、精準發酵、無細胞生物製造和人工智慧驅動的分子發現技術的進步正在從根本上改變全球生物同源化妝品活性成分市場。這些技術永續且強大的原料,例如重組膠原蛋白、客製化胜肽、微生物後生元和發酵衍生脂質。監管機構和市場對永續性、可追溯性、珊瑚礁安全以及逐步淘汰動物源和石油源原料的關注,正在加速這些新一代活性成分在護膚、皮膚化妝品以及美容與健康混合領域的應用。全球研究活動蓬勃發展,專利申請、同行評審出版物以及涵蓋皮膚病學、微生物組學、計算生物學和生物製造等領域的跨學科創新均顯著增加。

本報告全面評估了生物同源化妝品活性成分的技術、監管和商業性發展歷程,涵蓋了從人工智慧設計的胜肽到突破性技術(例如源自極端微生物的UV防曬過濾劑)等各個方面。此外,報告重點介紹了關鍵創新者、新興經營模式和高價值成長機遇,為希望在未來生物技術主導的化妝品生態系統中佔據領先地位的利益相關人員提供了策略性主導。 (註:本研究不包含市場規模預測,重點在於科學、技術和應用層面的進步。)

技術平台:

  • 精準發酵
  • 微藻類和藍菌發酵平台
  • 酵素和無細胞生物催化劑
  • 合成生物學和代謝工程平台

成分類別:

  • 重組蛋白和胜肽(膠原蛋白、訊號肽)
  • 發酵衍生的多醣體(玻尿酸、聚醣)
  • 生物等效脂質(角鯊烷、神經醯胺)
  • 生物發酵產生的抗氧化劑和類胡蘿蔔素
  • 源自植物細胞培養的活性成分(多酚、糖苷、植物代謝物)

目錄

策略要務

  • 為什麼經濟成長變得越來越困難?
  • 策略要務八要素™:阻礙成長的因素
  • 三大策略要務對化妝品中生物同源活性成分的影響
  • 成長機會能否推動「成長管道引擎™」的發展?
  • 調查方法

成長機會分析

  • 分析範圍
  • 調查細分
  • 化妝品中的生物活性:概述
  • 傳統生物活性成分萃取方法面臨的挑戰以及對生物技術手段的需求
  • 促進全球接受生物同源活性成分的監管和安全條件

成長要素

  • 成長促進因素
  • 成長抑制因素

化妝品中生物同源活性成分的技術進步

  • 生物同源性化妝品活性成分類別的發展趨勢
  • 利用發酵衍生的多醣體改善化妝品的保濕和補水性能。
  • 與傳統替代品相比,生物基抗氧化劑和類胡蘿蔔素可提供更優異的皮膚保護。
  • 利用生物技術製程提高高性能重組蛋白和胜肽的生產效率。
  • 生物同源脂質可改善護膚中的屏障修復方案
  • 利用植物細胞培養技術實現稀有植物化學活性成分的永續生產途徑
  • 生物同源化妝品活性成分的技術趨勢
  • 利用精準發酵技術,透過可程式設計生物製造實現高價值客製化活性成分的生產
  • 利用微藻類和藍菌發酵平台進行可擴展的生物生產,展現了經濟效益。
  • 利用酵素和無細胞生物催化劑實現清潔、目標導向的活性成分合成。
  • 引領下一代化妝品活性成分發展的合成生物學和代謝工程平台。

創新生態系統

  • 生物同源化妝品活性成分的商業化表明,人們明顯偏好發酵方法。
  • 與活性成分向生物技術製程過渡相一致的合作與策略夥伴關係。
  • 投資活動旨在促進生物同源活性成分在先進化妝品配方中的應用和推廣。

智慧財產權發展趨勢(2020-2025)

  • 為了滿足活性成分生產流程改善的需求,全球專利申請活動正在增加。
  • 支持生物同源性化妝品活性成分成長的研究活動

分析師意見

  • 加強商業和研究舉措,以改進合成生物學平台,用於客製化生物同源活性成分。
  • 先進的生物技術製程正在推動下一代生物同源化妝品活性成分的研發。

成長機會領域

  • 成長機會 1:用於發現新型化妝品胜肽和生物同源活性成分的人工智慧平台
  • 成長機會2:用於按需生產化妝品活性成分的無細胞生物製造
  • 成長機會3:微生物組衍生的訊號分子

附錄

  • 技術成熟度等級 (TRL):描述

下一步

  • 成長機會的益處和影響
  • 下一步
  • 免責聲明
簡介目錄
Product Code: DB67

Global Demand for Sustainable and Effective Ingredients Leading the Way for a New Generation of Science-First Cosmetic Innovations

The global market for bio-identical cosmetic actives is undergoing a structural transformation driven by advances in synthetic biology, precision fermentation, cell-free biomanufacturing, and AI-enabled molecule discovery. These technologies are enabling the production of highly targeted, sustainable, and functionally superior ingredients such as recombinant collagen, designer peptides, microbial postbiotics, and fermentation-derived lipids. Regulatory and market pressures centered on sustainability, traceability, reef safety, and the phase-down of animal- and petro-derived inputs are accelerating the adoption of these next-generation actives across skincare, dermocosmetics, and hybrid beauty-wellness categories. Research intensity is rising globally, with a notable increase in patents, peer-reviewed publications, and cross-disciplinary innovation spanning dermatology, microbiome science, computational biology, and biomanufacturing.

This report provides a comprehensive assessment of the technological, regulatory, and commercial evolution of bio-identical cosmetic actives, mapping breakthroughs from AI-designed peptides to extremophile-derived UV filters. It further highlights key innovators, emerging business models, and high-value growth opportunities, offering strategic insights for stakeholders seeking leadership in the future biotech-driven beauty ecosystem. (Note: This research excludes market sizing and forecasting. The focus will be on scientific, technological, and application-level advancements.)

Technology Platforms:

  • Precision Fermentation
  • Microalgae and Cyanobacteria Fermentation Platforms
  • Enzymatic and Cell-Free Biocatalysis
  • Synthetic Biology & Metabolic Engineering Platforms

Ingredient Categories:

  • Recombinant Proteins and Peptides (Collagen, Signal Peptides)
  • Fermentation-Derived Polysaccharides (Hyaluronic Acid, Glycans)
  • Bio-Identical Lipids (Squalane, Ceramides)
  • Bio-Fermented Antioxidants and Carotenoids
  • Plant-Cell-Culture Actives (Polyphenols, Glycosides, Botanical Metabolites)

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8TM: Factors Creating Pressure on Growth
  • The Impact of the Top 3 Strategic Imperatives on the Bio-Identical Actives in Cosmetics
  • Growth Opportunities Fuel the Growth Pipeline EngineTM
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Research Segmentation
  • Bio-Identical Actives in Cosmetics: Overview
  • Challenges in Conventional Extraction of Biological Actives Resulting in the Need for Biotechnological Approaches
  • Regulatory & Safety Landscape Promoting Global Acceptance of Bio-Identical Actives

Growth Generator

  • Growth Drivers
  • Growth Restraints

Technology Advancements in Bio-Identical Actives in Cosmetics

  • Trends in Bio-Identical Cosmetic Active Ingredient Categories
  • Fermentation-Derived Polysaccharides Improving Hydration and Moisturization of Cosmetic Products
  • Bio-Based Antioxidants & Carotenoids Providing Better Skin Defense Compared to Conventional Alternatives
  • Biotechnological Processes Improve Ease of Production for High Performance Recombinant Proteins and Peptides
  • Bio-Identical Lipids Improving Barrier Repair Solutions in Skincare
  • Plant Cell Culture Providing a Sustainable Route for Producing Rare Phytochemical Actives
  • Technology Trends in Bio-Identical Cosmetic Actives
  • Programmable Biomanufacturing with Precision Fermentation Enabling Production of High-Value Designer Actives
  • Scalable Bioproduction with Microalgae and Cyanobacteria Fermentation Platforms Proving to be Economically Efficient
  • Enzymatic and Cell-Free Biocatalysis Enabling Clean, Targeted Active Ingredient Synthesis
  • Synthetic Biology & Metabolic Engineering Platforms to Lead the Way for the Next Generation of Cosmetic Actives

Innovation Ecosystem

  • Bio-Identical Cosmetic Active Commercialization Activities Indicates Clear Preference for Fermentation Methods
  • Collaborations and Strategic Partnerships Aligned with Shift to Biotechnological Processes for Actives
  • Investment Activities Fueling the Growth and Adoption of Bio-Identical Actives for Advanced Cosmetic Formulations

IP Landscaping (2020-2025)

  • Patent Filing Activities Growing Globally to Meet the Needs for Improved Processes for Active Ingredients
  • Research Activities Supporting the Growth of Bio-Identical Cosmetic Actives

Analyst Perspective

  • Commercial & Research Initiatives to Intensify in Improving Synthetic Biology Platforms for Customized Bio-Identical Actives
  • Advanced Biotechnological Processes Leading the Way Forward for the Next Generation of Bio-Identical Cosmetic Actives

Growth Opportunity Universe

  • Growth Opportunity 1: AI-Powered Discovery Platforms for Novel Cosmetic Peptides and Bio-Identical Actives
  • Growth Opportunity 2: Cell-Free Biomanufacturing for On-Demand Cosmetic Active Production
  • Growth Opportunity 3: Microbiome-Derived Signaling Molecules

Appendix

  • Technology Readiness Levels (TRL): Explanation

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer